nodes	percent_of_prediction	percent_of_DWPC	metapath
Sofosbuvir—Nucleoside Analog—Azathioprine—multiple sclerosis	0.749	1	CiPCiCtD
Sofosbuvir—ABCB1—Methylprednisolone—multiple sclerosis	0.0443	0.232	CbGbCtD
Sofosbuvir—ABCB1—Mitoxantrone—multiple sclerosis	0.0323	0.169	CbGbCtD
Sofosbuvir—ABCB1—Betamethasone—multiple sclerosis	0.0288	0.151	CbGbCtD
Sofosbuvir—ABCB1—Prednisolone—multiple sclerosis	0.0284	0.149	CbGbCtD
Sofosbuvir—ABCB1—Prednisone—multiple sclerosis	0.0268	0.141	CbGbCtD
Sofosbuvir—ABCB1—Dexamethasone—multiple sclerosis	0.0168	0.0878	CbGbCtD
Sofosbuvir—ABCB1—Methotrexate—multiple sclerosis	0.0135	0.0705	CbGbCtD
Sofosbuvir—Alopecia—Azathioprine—multiple sclerosis	0.000263	0.00434	CcSEcCtD
Sofosbuvir—Dry skin—Prednisolone—multiple sclerosis	0.000261	0.00431	CcSEcCtD
Sofosbuvir—Infection—Cladribine—multiple sclerosis	0.000258	0.00426	CcSEcCtD
Sofosbuvir—Nervous system disorder—Cladribine—multiple sclerosis	0.000255	0.00421	CcSEcCtD
Sofosbuvir—Skin disorder—Cladribine—multiple sclerosis	0.000252	0.00417	CcSEcCtD
Sofosbuvir—Irritability—Methylprednisolone—multiple sclerosis	0.00025	0.00412	CcSEcCtD
Sofosbuvir—Anaemia—Azathioprine—multiple sclerosis	0.000239	0.00395	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.000237	0.00391	CcSEcCtD
Sofosbuvir—Insomnia—Cladribine—multiple sclerosis	0.000235	0.00388	CcSEcCtD
Sofosbuvir—Migraine—Betamethasone—multiple sclerosis	0.000234	0.00386	CcSEcCtD
Sofosbuvir—Migraine—Dexamethasone—multiple sclerosis	0.000234	0.00386	CcSEcCtD
Sofosbuvir—Dyspnoea—Cladribine—multiple sclerosis	0.000232	0.00382	CcSEcCtD
Sofosbuvir—Irritability—Dexamethasone—multiple sclerosis	0.000227	0.00375	CcSEcCtD
Sofosbuvir—Irritability—Betamethasone—multiple sclerosis	0.000227	0.00375	CcSEcCtD
Sofosbuvir—Decreased appetite—Cladribine—multiple sclerosis	0.000226	0.00373	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000224	0.0037	CcSEcCtD
Sofosbuvir—Fatigue—Cladribine—multiple sclerosis	0.000224	0.0037	CcSEcCtD
Sofosbuvir—Pain—Cladribine—multiple sclerosis	0.000222	0.00367	CcSEcCtD
Sofosbuvir—Constipation—Cladribine—multiple sclerosis	0.000222	0.00367	CcSEcCtD
Sofosbuvir—Arthralgia—Azathioprine—multiple sclerosis	0.00022	0.00364	CcSEcCtD
Sofosbuvir—Myalgia—Azathioprine—multiple sclerosis	0.00022	0.00364	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000219	0.00361	CcSEcCtD
Sofosbuvir—Dry skin—Betamethasone—multiple sclerosis	0.000218	0.0036	CcSEcCtD
Sofosbuvir—Dry skin—Dexamethasone—multiple sclerosis	0.000218	0.0036	CcSEcCtD
Sofosbuvir—Chills—Mitoxantrone—multiple sclerosis	0.000216	0.00356	CcSEcCtD
Sofosbuvir—Alopecia—Mitoxantrone—multiple sclerosis	0.000212	0.00351	CcSEcCtD
Sofosbuvir—Infection—Azathioprine—multiple sclerosis	0.00021	0.00346	CcSEcCtD
Sofosbuvir—Body temperature increased—Cladribine—multiple sclerosis	0.000205	0.00339	CcSEcCtD
Sofosbuvir—Skin disorder—Azathioprine—multiple sclerosis	0.000205	0.00339	CcSEcCtD
Sofosbuvir—Back pain—Mitoxantrone—multiple sclerosis	0.000202	0.00334	CcSEcCtD
Sofosbuvir—Infestation NOS—Methylprednisolone—multiple sclerosis	0.000201	0.00333	CcSEcCtD
Sofosbuvir—Infestation—Methylprednisolone—multiple sclerosis	0.000201	0.00333	CcSEcCtD
Sofosbuvir—Irritability—Prednisone—multiple sclerosis	0.000198	0.00326	CcSEcCtD
Sofosbuvir—Vision blurred—Mitoxantrone—multiple sclerosis	0.000197	0.00326	CcSEcCtD
Sofosbuvir—Anaemia—Mitoxantrone—multiple sclerosis	0.000193	0.00319	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000192	0.00318	CcSEcCtD
Sofosbuvir—Dry skin—Prednisone—multiple sclerosis	0.00019	0.00313	CcSEcCtD
Sofosbuvir—Asthenia—Cladribine—multiple sclerosis	0.000186	0.00308	CcSEcCtD
Sofosbuvir—Weight decreased—Dexamethasone—multiple sclerosis	0.000186	0.00307	CcSEcCtD
Sofosbuvir—Weight decreased—Betamethasone—multiple sclerosis	0.000186	0.00307	CcSEcCtD
Sofosbuvir—Pruritus—Cladribine—multiple sclerosis	0.000184	0.00303	CcSEcCtD
Sofosbuvir—Cough—Mitoxantrone—multiple sclerosis	0.000183	0.00301	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000182	0.00301	CcSEcCtD
Sofosbuvir—Arthralgia—Mitoxantrone—multiple sclerosis	0.000178	0.00294	CcSEcCtD
Sofosbuvir—Myalgia—Mitoxantrone—multiple sclerosis	0.000178	0.00294	CcSEcCtD
Sofosbuvir—Chest pain—Mitoxantrone—multiple sclerosis	0.000178	0.00294	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000178	0.00294	CcSEcCtD
Sofosbuvir—Diarrhoea—Cladribine—multiple sclerosis	0.000178	0.00293	CcSEcCtD
Sofosbuvir—Anxiety—Mitoxantrone—multiple sclerosis	0.000177	0.00293	CcSEcCtD
Sofosbuvir—Dizziness—Cladribine—multiple sclerosis	0.000172	0.00284	CcSEcCtD
Sofosbuvir—Infection—Mitoxantrone—multiple sclerosis	0.00017	0.0028	CcSEcCtD
Sofosbuvir—Eye disorder—Methylprednisolone—multiple sclerosis	0.000169	0.00279	CcSEcCtD
Sofosbuvir—Neutropenia—Prednisone—multiple sclerosis	0.000167	0.00276	CcSEcCtD
Sofosbuvir—Body temperature increased—Azathioprine—multiple sclerosis	0.000167	0.00276	CcSEcCtD
Sofosbuvir—Skin disorder—Mitoxantrone—multiple sclerosis	0.000166	0.00274	CcSEcCtD
Sofosbuvir—Irritability—Methotrexate—multiple sclerosis	0.000165	0.00273	CcSEcCtD
Sofosbuvir—Vomiting—Cladribine—multiple sclerosis	0.000165	0.00273	CcSEcCtD
Sofosbuvir—Rash—Cladribine—multiple sclerosis	0.000164	0.0027	CcSEcCtD
Sofosbuvir—Dermatitis—Cladribine—multiple sclerosis	0.000164	0.0027	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000163	0.00269	CcSEcCtD
Sofosbuvir—Headache—Cladribine—multiple sclerosis	0.000163	0.00269	CcSEcCtD
Sofosbuvir—Weight decreased—Prednisone—multiple sclerosis	0.000162	0.00267	CcSEcCtD
Sofosbuvir—Vision blurred—Prednisolone—multiple sclerosis	0.000162	0.00267	CcSEcCtD
Sofosbuvir—Malnutrition—Methylprednisolone—multiple sclerosis	0.000157	0.0026	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000156	0.00257	CcSEcCtD
Sofosbuvir—Nausea—Cladribine—multiple sclerosis	0.000154	0.00255	CcSEcCtD
Sofosbuvir—Eye disorder—Dexamethasone—multiple sclerosis	0.000154	0.00254	CcSEcCtD
Sofosbuvir—Eye disorder—Betamethasone—multiple sclerosis	0.000154	0.00254	CcSEcCtD
Sofosbuvir—Back pain—Triamcinolone—multiple sclerosis	0.000153	0.00252	CcSEcCtD
Sofosbuvir—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000152	0.00251	CcSEcCtD
Sofosbuvir—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00015	0.00248	CcSEcCtD
Sofosbuvir—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000148	0.00245	CcSEcCtD
Sofosbuvir—Fatigue—Mitoxantrone—multiple sclerosis	0.000147	0.00243	CcSEcCtD
Sofosbuvir—Pain—Mitoxantrone—multiple sclerosis	0.000146	0.00241	CcSEcCtD
Sofosbuvir—Constipation—Mitoxantrone—multiple sclerosis	0.000146	0.00241	CcSEcCtD
Sofosbuvir—Alopecia—Dexamethasone—multiple sclerosis	0.000145	0.0024	CcSEcCtD
Sofosbuvir—Alopecia—Betamethasone—multiple sclerosis	0.000145	0.0024	CcSEcCtD
Sofosbuvir—Diarrhoea—Azathioprine—multiple sclerosis	0.000144	0.00239	CcSEcCtD
Sofosbuvir—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000143	0.00237	CcSEcCtD
Sofosbuvir—Pancytopenia—Methotrexate—multiple sclerosis	0.000142	0.00235	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Prednisone—multiple sclerosis	0.000141	0.00232	CcSEcCtD
Sofosbuvir—Neutropenia—Methotrexate—multiple sclerosis	0.00014	0.00231	CcSEcCtD
Sofosbuvir—Dizziness—Azathioprine—multiple sclerosis	0.00014	0.00231	CcSEcCtD
Sofosbuvir—Cough—Triamcinolone—multiple sclerosis	0.000138	0.00227	CcSEcCtD
Sofosbuvir—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000135	0.00223	CcSEcCtD
Sofosbuvir—Myalgia—Triamcinolone—multiple sclerosis	0.000134	0.00222	CcSEcCtD
Sofosbuvir—Vomiting—Azathioprine—multiple sclerosis	0.000134	0.00222	CcSEcCtD
Sofosbuvir—Arthralgia—Methylprednisolone—multiple sclerosis	0.000134	0.00221	CcSEcCtD
Sofosbuvir—Myalgia—Methylprednisolone—multiple sclerosis	0.000134	0.00221	CcSEcCtD
Sofosbuvir—Eye disorder—Prednisone—multiple sclerosis	0.000134	0.00221	CcSEcCtD
Sofosbuvir—Anxiety—Methylprednisolone—multiple sclerosis	0.000134	0.00221	CcSEcCtD
Sofosbuvir—Infestation NOS—Methotrexate—multiple sclerosis	0.000133	0.0022	CcSEcCtD
Sofosbuvir—Infestation—Methotrexate—multiple sclerosis	0.000133	0.0022	CcSEcCtD
Sofosbuvir—Rash—Azathioprine—multiple sclerosis	0.000133	0.0022	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000133	0.0022	CcSEcCtD
Sofosbuvir—Dermatitis—Azathioprine—multiple sclerosis	0.000133	0.0022	CcSEcCtD
Sofosbuvir—Headache—Azathioprine—multiple sclerosis	0.000132	0.00218	CcSEcCtD
Sofosbuvir—Dry mouth—Triamcinolone—multiple sclerosis	0.000131	0.00217	CcSEcCtD
Sofosbuvir—Infection—Triamcinolone—multiple sclerosis	0.000128	0.00211	CcSEcCtD
Sofosbuvir—Infection—Methylprednisolone—multiple sclerosis	0.000128	0.00211	CcSEcCtD
Sofosbuvir—Insomnia—Prednisolone—multiple sclerosis	0.000127	0.00209	CcSEcCtD
Sofosbuvir—Alopecia—Prednisone—multiple sclerosis	0.000127	0.00209	CcSEcCtD
Sofosbuvir—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000126	0.00208	CcSEcCtD
Sofosbuvir—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000126	0.00208	CcSEcCtD
Sofosbuvir—Nausea—Azathioprine—multiple sclerosis	0.000125	0.00207	CcSEcCtD
Sofosbuvir—Skin disorder—Methylprednisolone—multiple sclerosis	0.000125	0.00206	CcSEcCtD
Sofosbuvir—Malnutrition—Prednisone—multiple sclerosis	0.000125	0.00206	CcSEcCtD
Sofosbuvir—Asthenia—Mitoxantrone—multiple sclerosis	0.000122	0.00202	CcSEcCtD
Sofosbuvir—Myalgia—Betamethasone—multiple sclerosis	0.000122	0.00201	CcSEcCtD
Sofosbuvir—Myalgia—Dexamethasone—multiple sclerosis	0.000122	0.00201	CcSEcCtD
Sofosbuvir—Anxiety—Betamethasone—multiple sclerosis	0.000121	0.00201	CcSEcCtD
Sofosbuvir—Anxiety—Dexamethasone—multiple sclerosis	0.000121	0.00201	CcSEcCtD
Sofosbuvir—Pain—Prednisolone—multiple sclerosis	0.00012	0.00198	CcSEcCtD
Sofosbuvir—Vision blurred—Prednisone—multiple sclerosis	0.000118	0.00194	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000117	0.00194	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000117	0.00193	CcSEcCtD
Sofosbuvir—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000117	0.00193	CcSEcCtD
Sofosbuvir—Insomnia—Triamcinolone—multiple sclerosis	0.000116	0.00192	CcSEcCtD
Sofosbuvir—Insomnia—Methylprednisolone—multiple sclerosis	0.000116	0.00192	CcSEcCtD
Sofosbuvir—Infection—Dexamethasone—multiple sclerosis	0.000116	0.00192	CcSEcCtD
Sofosbuvir—Infection—Betamethasone—multiple sclerosis	0.000116	0.00192	CcSEcCtD
Sofosbuvir—Anaemia—Prednisone—multiple sclerosis	0.000115	0.0019	CcSEcCtD
Sofosbuvir—Dyspnoea—Triamcinolone—multiple sclerosis	0.000115	0.0019	CcSEcCtD
Sofosbuvir—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000115	0.00189	CcSEcCtD
Sofosbuvir—Nervous system disorder—Betamethasone—multiple sclerosis	0.000115	0.00189	CcSEcCtD
Sofosbuvir—Agitation—Prednisone—multiple sclerosis	0.000115	0.00189	CcSEcCtD
Sofosbuvir—Dyspepsia—Triamcinolone—multiple sclerosis	0.000113	0.00187	CcSEcCtD
Sofosbuvir—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000113	0.00187	CcSEcCtD
Sofosbuvir—Eye disorder—Methotrexate—multiple sclerosis	0.000112	0.00185	CcSEcCtD
Sofosbuvir—Fatigue—Triamcinolone—multiple sclerosis	0.000111	0.00183	CcSEcCtD
Sofosbuvir—Fatigue—Methylprednisolone—multiple sclerosis	0.000111	0.00183	CcSEcCtD
Sofosbuvir—Pain—Triamcinolone—multiple sclerosis	0.00011	0.00182	CcSEcCtD
Sofosbuvir—Vomiting—Mitoxantrone—multiple sclerosis	0.000109	0.00179	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000108	0.00178	CcSEcCtD
Sofosbuvir—Rash—Mitoxantrone—multiple sclerosis	0.000108	0.00178	CcSEcCtD
Sofosbuvir—Dermatitis—Mitoxantrone—multiple sclerosis	0.000108	0.00178	CcSEcCtD
Sofosbuvir—Chills—Methotrexate—multiple sclerosis	0.000107	0.00177	CcSEcCtD
Sofosbuvir—Headache—Mitoxantrone—multiple sclerosis	0.000107	0.00177	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000106	0.00176	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000106	0.00176	CcSEcCtD
Sofosbuvir—Arthralgia—Prednisone—multiple sclerosis	0.000106	0.00175	CcSEcCtD
Sofosbuvir—Myalgia—Prednisone—multiple sclerosis	0.000106	0.00175	CcSEcCtD
Sofosbuvir—Anxiety—Prednisone—multiple sclerosis	0.000106	0.00175	CcSEcCtD
Sofosbuvir—Alopecia—Methotrexate—multiple sclerosis	0.000106	0.00175	CcSEcCtD
Sofosbuvir—Insomnia—Dexamethasone—multiple sclerosis	0.000106	0.00175	CcSEcCtD
Sofosbuvir—Insomnia—Betamethasone—multiple sclerosis	0.000106	0.00175	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000105	0.00174	CcSEcCtD
Sofosbuvir—Malnutrition—Methotrexate—multiple sclerosis	0.000104	0.00172	CcSEcCtD
Sofosbuvir—Dyspepsia—Dexamethasone—multiple sclerosis	0.000103	0.0017	CcSEcCtD
Sofosbuvir—Dyspepsia—Betamethasone—multiple sclerosis	0.000103	0.0017	CcSEcCtD
Sofosbuvir—Body temperature increased—Triamcinolone—multiple sclerosis	0.000102	0.00168	CcSEcCtD
Sofosbuvir—Decreased appetite—Betamethasone—multiple sclerosis	0.000102	0.00168	CcSEcCtD
Sofosbuvir—Decreased appetite—Dexamethasone—multiple sclerosis	0.000102	0.00168	CcSEcCtD
Sofosbuvir—Nausea—Mitoxantrone—multiple sclerosis	0.000101	0.00167	CcSEcCtD
Sofosbuvir—Infection—Prednisone—multiple sclerosis	0.000101	0.00167	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000101	0.00167	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000101	0.00167	CcSEcCtD
Sofosbuvir—Back pain—Methotrexate—multiple sclerosis	0.000101	0.00166	CcSEcCtD
Sofosbuvir—Fatigue—Dexamethasone—multiple sclerosis	0.000101	0.00166	CcSEcCtD
Sofosbuvir—Fatigue—Betamethasone—multiple sclerosis	0.000101	0.00166	CcSEcCtD
Sofosbuvir—Pain—Betamethasone—multiple sclerosis	9.99e-05	0.00165	CcSEcCtD
Sofosbuvir—Pain—Dexamethasone—multiple sclerosis	9.99e-05	0.00165	CcSEcCtD
Sofosbuvir—Nervous system disorder—Prednisone—multiple sclerosis	9.98e-05	0.00165	CcSEcCtD
Sofosbuvir—Skin disorder—Prednisone—multiple sclerosis	9.88e-05	0.00163	CcSEcCtD
Sofosbuvir—Vision blurred—Methotrexate—multiple sclerosis	9.82e-05	0.00162	CcSEcCtD
Sofosbuvir—Anaemia—Methotrexate—multiple sclerosis	9.63e-05	0.00159	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Prednisone—multiple sclerosis	9.27e-05	0.00153	CcSEcCtD
Sofosbuvir—Dizziness—Prednisolone—multiple sclerosis	9.26e-05	0.00153	CcSEcCtD
Sofosbuvir—Asthenia—Triamcinolone—multiple sclerosis	9.24e-05	0.00153	CcSEcCtD
Sofosbuvir—Body temperature increased—Betamethasone—multiple sclerosis	9.24e-05	0.00153	CcSEcCtD
Sofosbuvir—Body temperature increased—Dexamethasone—multiple sclerosis	9.24e-05	0.00153	CcSEcCtD
Sofosbuvir—Asthenia—Methylprednisolone—multiple sclerosis	9.22e-05	0.00152	CcSEcCtD
Sofosbuvir—Insomnia—Prednisone—multiple sclerosis	9.2e-05	0.00152	CcSEcCtD
Sofosbuvir—Pruritus—Triamcinolone—multiple sclerosis	9.11e-05	0.0015	CcSEcCtD
Sofosbuvir—Cough—Methotrexate—multiple sclerosis	9.09e-05	0.0015	CcSEcCtD
Sofosbuvir—Pruritus—Methylprednisolone—multiple sclerosis	9.09e-05	0.0015	CcSEcCtD
Sofosbuvir—Dyspepsia—Prednisone—multiple sclerosis	8.96e-05	0.00148	CcSEcCtD
Sofosbuvir—Myalgia—Methotrexate—multiple sclerosis	8.87e-05	0.00147	CcSEcCtD
Sofosbuvir—Arthralgia—Methotrexate—multiple sclerosis	8.87e-05	0.00147	CcSEcCtD
Sofosbuvir—Chest pain—Methotrexate—multiple sclerosis	8.87e-05	0.00147	CcSEcCtD
Sofosbuvir—Decreased appetite—Prednisone—multiple sclerosis	8.85e-05	0.00146	CcSEcCtD
Sofosbuvir—Rash—Prednisolone—multiple sclerosis	8.83e-05	0.00146	CcSEcCtD
Sofosbuvir—Dermatitis—Prednisolone—multiple sclerosis	8.82e-05	0.00146	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	8.81e-05	0.00145	CcSEcCtD
Sofosbuvir—Diarrhoea—Methylprednisolone—multiple sclerosis	8.79e-05	0.00145	CcSEcCtD
Sofosbuvir—Fatigue—Prednisone—multiple sclerosis	8.77e-05	0.00145	CcSEcCtD
Sofosbuvir—Headache—Prednisolone—multiple sclerosis	8.77e-05	0.00145	CcSEcCtD
Sofosbuvir—Constipation—Prednisone—multiple sclerosis	8.7e-05	0.00144	CcSEcCtD
Sofosbuvir—Dizziness—Triamcinolone—multiple sclerosis	8.52e-05	0.00141	CcSEcCtD
Sofosbuvir—Dizziness—Methylprednisolone—multiple sclerosis	8.5e-05	0.0014	CcSEcCtD
Sofosbuvir—Infection—Methotrexate—multiple sclerosis	8.45e-05	0.0014	CcSEcCtD
Sofosbuvir—Asthenia—Betamethasone—multiple sclerosis	8.38e-05	0.00138	CcSEcCtD
Sofosbuvir—Asthenia—Dexamethasone—multiple sclerosis	8.38e-05	0.00138	CcSEcCtD
Sofosbuvir—Nervous system disorder—Methotrexate—multiple sclerosis	8.34e-05	0.00138	CcSEcCtD
Sofosbuvir—Nausea—Prednisolone—multiple sclerosis	8.32e-05	0.00137	CcSEcCtD
Sofosbuvir—Pruritus—Dexamethasone—multiple sclerosis	8.27e-05	0.00137	CcSEcCtD
Sofosbuvir—Pruritus—Betamethasone—multiple sclerosis	8.27e-05	0.00137	CcSEcCtD
Sofosbuvir—Skin disorder—Methotrexate—multiple sclerosis	8.26e-05	0.00136	CcSEcCtD
Sofosbuvir—Vomiting—Triamcinolone—multiple sclerosis	8.19e-05	0.00135	CcSEcCtD
Sofosbuvir—Vomiting—Methylprednisolone—multiple sclerosis	8.17e-05	0.00135	CcSEcCtD
Sofosbuvir—Rash—Triamcinolone—multiple sclerosis	8.12e-05	0.00134	CcSEcCtD
Sofosbuvir—Dermatitis—Triamcinolone—multiple sclerosis	8.11e-05	0.00134	CcSEcCtD
Sofosbuvir—Rash—Methylprednisolone—multiple sclerosis	8.1e-05	0.00134	CcSEcCtD
Sofosbuvir—Dermatitis—Methylprednisolone—multiple sclerosis	8.09e-05	0.00134	CcSEcCtD
Sofosbuvir—Headache—Triamcinolone—multiple sclerosis	8.07e-05	0.00133	CcSEcCtD
Sofosbuvir—Headache—Methylprednisolone—multiple sclerosis	8.05e-05	0.00133	CcSEcCtD
Sofosbuvir—Body temperature increased—Prednisone—multiple sclerosis	8.04e-05	0.00133	CcSEcCtD
Sofosbuvir—Diarrhoea—Dexamethasone—multiple sclerosis	7.99e-05	0.00132	CcSEcCtD
Sofosbuvir—Diarrhoea—Betamethasone—multiple sclerosis	7.99e-05	0.00132	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	7.75e-05	0.00128	CcSEcCtD
Sofosbuvir—Dizziness—Betamethasone—multiple sclerosis	7.73e-05	0.00128	CcSEcCtD
Sofosbuvir—Dizziness—Dexamethasone—multiple sclerosis	7.73e-05	0.00128	CcSEcCtD
Sofosbuvir—Insomnia—Methotrexate—multiple sclerosis	7.69e-05	0.00127	CcSEcCtD
Sofosbuvir—Nausea—Triamcinolone—multiple sclerosis	7.65e-05	0.00126	CcSEcCtD
Sofosbuvir—Nausea—Methylprednisolone—multiple sclerosis	7.63e-05	0.00126	CcSEcCtD
Sofosbuvir—Dyspnoea—Methotrexate—multiple sclerosis	7.58e-05	0.00125	CcSEcCtD
Sofosbuvir—Dyspepsia—Methotrexate—multiple sclerosis	7.49e-05	0.00124	CcSEcCtD
Sofosbuvir—Vomiting—Betamethasone—multiple sclerosis	7.43e-05	0.00123	CcSEcCtD
Sofosbuvir—Vomiting—Dexamethasone—multiple sclerosis	7.43e-05	0.00123	CcSEcCtD
Sofosbuvir—Decreased appetite—Methotrexate—multiple sclerosis	7.39e-05	0.00122	CcSEcCtD
Sofosbuvir—Rash—Dexamethasone—multiple sclerosis	7.37e-05	0.00122	CcSEcCtD
Sofosbuvir—Rash—Betamethasone—multiple sclerosis	7.37e-05	0.00122	CcSEcCtD
Sofosbuvir—Dermatitis—Dexamethasone—multiple sclerosis	7.36e-05	0.00122	CcSEcCtD
Sofosbuvir—Dermatitis—Betamethasone—multiple sclerosis	7.36e-05	0.00122	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Methotrexate—multiple sclerosis	7.34e-05	0.00121	CcSEcCtD
Sofosbuvir—Fatigue—Methotrexate—multiple sclerosis	7.33e-05	0.00121	CcSEcCtD
Sofosbuvir—Headache—Betamethasone—multiple sclerosis	7.32e-05	0.00121	CcSEcCtD
Sofosbuvir—Headache—Dexamethasone—multiple sclerosis	7.32e-05	0.00121	CcSEcCtD
Sofosbuvir—Asthenia—Prednisone—multiple sclerosis	7.3e-05	0.00121	CcSEcCtD
Sofosbuvir—Pain—Methotrexate—multiple sclerosis	7.27e-05	0.0012	CcSEcCtD
Sofosbuvir—Pruritus—Prednisone—multiple sclerosis	7.2e-05	0.00119	CcSEcCtD
Sofosbuvir—Diarrhoea—Prednisone—multiple sclerosis	6.96e-05	0.00115	CcSEcCtD
Sofosbuvir—Nausea—Betamethasone—multiple sclerosis	6.94e-05	0.00115	CcSEcCtD
Sofosbuvir—Nausea—Dexamethasone—multiple sclerosis	6.94e-05	0.00115	CcSEcCtD
Sofosbuvir—Dizziness—Prednisone—multiple sclerosis	6.73e-05	0.00111	CcSEcCtD
Sofosbuvir—Body temperature increased—Methotrexate—multiple sclerosis	6.72e-05	0.00111	CcSEcCtD
Sofosbuvir—Vomiting—Prednisone—multiple sclerosis	6.47e-05	0.00107	CcSEcCtD
Sofosbuvir—Rash—Prednisone—multiple sclerosis	6.42e-05	0.00106	CcSEcCtD
Sofosbuvir—Dermatitis—Prednisone—multiple sclerosis	6.41e-05	0.00106	CcSEcCtD
Sofosbuvir—Headache—Prednisone—multiple sclerosis	6.37e-05	0.00105	CcSEcCtD
Sofosbuvir—Asthenia—Methotrexate—multiple sclerosis	6.1e-05	0.00101	CcSEcCtD
Sofosbuvir—Nausea—Prednisone—multiple sclerosis	6.04e-05	0.000998	CcSEcCtD
Sofosbuvir—Pruritus—Methotrexate—multiple sclerosis	6.02e-05	0.000994	CcSEcCtD
Sofosbuvir—Diarrhoea—Methotrexate—multiple sclerosis	5.82e-05	0.000961	CcSEcCtD
Sofosbuvir—Dizziness—Methotrexate—multiple sclerosis	5.62e-05	0.000929	CcSEcCtD
Sofosbuvir—Vomiting—Methotrexate—multiple sclerosis	5.41e-05	0.000893	CcSEcCtD
Sofosbuvir—Rash—Methotrexate—multiple sclerosis	5.36e-05	0.000886	CcSEcCtD
Sofosbuvir—Dermatitis—Methotrexate—multiple sclerosis	5.36e-05	0.000885	CcSEcCtD
Sofosbuvir—Headache—Methotrexate—multiple sclerosis	5.33e-05	0.00088	CcSEcCtD
Sofosbuvir—Nausea—Methotrexate—multiple sclerosis	5.05e-05	0.000834	CcSEcCtD
